Science Current Events | Science News | Brightsurf.com
 

Gene chip data improved therapy in some patients with incurable cancer

September 20, 2007
ATLANTA - Like many oncologists, Eric P. Lester, M.D., was faced with a dilemma: seven patients with advanced, incurable cancer, an arsenal of drugs that may or may not help them, and not enough solid proof about treatment efficacy to guide him. So Dr. Lester devised what he called a "simple-minded experiment" that illustrates the promise of personalized medicine. Using DNA microarray "chips," Dr. Lester analyzed his patients' tumors for expression of genes associated with good response to various anti-cancer drugs, and based his drug treatment plans on the results. Four out of seven patients with advanced cancer enrolled in the extremely limited study had a better outcome than expected.

The finding, presented today in Atlanta, Ga. at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, shows that "a personalized molecular oncology approach, basing chemotherapy on relative gene expression in tumors, holds promise even at the relatively crude level employed here," said study investigator, Dr. Lester, president of Oncology Care Associates in St. Joseph, Mich.

To obtain and analyze chip data, Dr. Lester worked with Craig Webb, Ph.D., Director of Translational Medicine at the Van Andel Research Institute in Grand Rapids, Mich.

The study is unusual because oncologists don't yet base most of their treatment decisions on gene profiling, especially when it might involve pairing drugs together in a novel combination or using varied doses, Dr. Lester said. "Much of clinical medicine is an educated guess, and this was an attempt to come up with a better approach by using the technology of a gene chip to make multiple, highly educated guesses simultaneously," Dr. Lester said.

Dr. Lester added that one of the seven participating patients died before the gene chip was used to direct therapy.

Many current clinical trials involving gene expression examine effectiveness markers for individual drugs rather than combinations of drugs or different doses of agents used together for the first time. To truly help the most patients, Dr. Lester said, all potentially effective drugs and combinations must be matched up against the unique genetic profile of a patient's tumor, he said.

"Effective cancer treatment depends on understanding the biology driving the cancer, but because each tumor is different, it is very hard to personalize care and do a rigorous scientific experiment at the same time."

In this study, Dr. Lester said he "stayed within the envelope of a reasonable standard of care" in treating his patients. That standard is often based on what insurance companies will typically reimburse for treatment given published studies about the effectiveness of a drug on a certain tumor type, and whether or not the drug is federally approved for that indication. Dr. Lester and Webb surveyed the scientific literature and compiled a list of genes whose expression levels may predict response to a drug given the tumor type.

In some cases, treatment strategies suggested by the chips varied significantly even for the same type of cancer. For example, one patient whose lung cancer had spread to his brain and bones achieved a "near complete response" when treated with two chemotherapy drugs, in addition to Tarceva and Avastin, while another lung cancer patient responded to third-line drugs such as etoposide.

Acknowledging the risk involved with using novel combinations of drugs where no set safety profile exists, Dr. Lester said that "this is constantly done in medicine. People are taking antibiotics at the same time as using heart and cholesterol pills, and blood pressure medication."

"This kind of polypharmacy will become more common in cancer, but at the moment, it is hard to figure out the difference between doses that are effective or that could be toxic," he said.

The best way to get around such issues is to build a database of gene expression data and match them with patient outcomes, he said. "Now when I see new patients I am itching to look at what the genes can tell me," Dr. Lester said. "It is a smarter way to treat cancer."

American Association for Cancer Research


Related Cancer Current Events and Cancer News Articles


Racial disparity in cancer mortality is narrowing, suggests new study
Cancer mortality remains significantly elevated among African Americans. Between 2000 and 2010, overall mortality from cancer decreased faster among African American women and men than among Caucasians.

Inside health-reform savings
In the first year of Medicare's Pioneer Accountable Care Organization program, the 32 participating provider organizations achieved a 1.2% savings while maintaining or improving performance on measures of quality of patient care.

Anti-fungal drug shows promise as potential new cancer treatment
A common anti-fungal treatment has joined the ranks of drugs that may be suitable for use in treating cancer, according to research from the Repurposing Drugs in Oncology (ReDO) project published in ecancermedicalscience.

GW Cancer Institute publishes core competencies for oncology patient navigators
The George Washington University (GW) Cancer Institute has finalized 45 core competency statements for oncology patient navigators, who have become critical members of the health care team.

New '4-D' lung cancer model could quicken discoveries
Without good models to study cancer metastasis -- the spread of cancer cells from one organ to another -- cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.

New genomic research amends earlier triple negative breast cancer finding
Weill Cornell Medical College investigators tried to validate a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease.

Big data key to precision medicine's success
Technological advances are enabling scientists to sequence the genomes of cancer tumors, revealing a detailed portrait of genetic mutations that drive these diseases.

NIST develops NMR 'fingerprinting' for monoclonal antibodies
National Institute of Standards and Technology (NIST) researchers at the Institute for Bioscience and Biotechnology Research (IBBR) have demonstrated the most precise method yet to measure the structural configuration of monoclonal antibodies (mAbs), an important factor in determining the safety and efficacy of these biomolecules as medicines.

A new mouse model for the study of neurofibromatosis
The research group of the neurofibromatosis of the Catalan Institute of Oncology (ICO), the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Institute of Medicicina Predictive and Personalized Cancer (IMPPC) has developed new mouse models for the study of principal malignant tumor associated with neurofibromatosis type 1.

Keep moving, studies advise cancer survivors
Three or more hours of walking per week can boost the vitality and health of prostate cancer survivors. Men and women who have survived colorectal cancer and are regular walkers as well report lower sensations of burning, numbness, tingling or loss of reflexes that many often experience post-treatment.
More Cancer Current Events and Cancer News Articles

The Emperor of All Maladies: A Biography of Cancer

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)


Winner of the Pulitzer Prize, and now a documentary from Ken Burns on PBS, The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence.

Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years.

The story of cancer is a story of human ingenuity, resilience, and perseverance,...

Anticancer: A New Way of Life

Anticancer: A New Way of Life
by David Servan-Schreiber (Author)


Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition of Anticancer includes:

• The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market
• New information about how vitamin D strengthens the immune system
• Warnings about common food contaminants that have recently been proven to contribute to cancer progression
• A new chapter on mind-body approaches to stress reduction, with recent studies that show how our reactions to stress can interfere with...

Cancer: What I Wish I Had Known When I Was First Diagnosed: Tips and Advice From a Survivor

Cancer: What I Wish I Had Known When I Was First Diagnosed: Tips and Advice From a Survivor
by Michele Ryan (Author)


A cancer diagnosis results, understandably, in fear and uncertainty. Once the initial shock passes, the questions begin. Some are medical in nature: What are your treatment options? Some are intensely personal: How do you tell your children? Will your hair grow back after chemo? How will the disease affect your sex life and relationships? In Cancer: What I Wish I Had Known When I Was First Diagnosed, ten-year breast cancer survivor Michele Ryan answers these questions and more. Michele's common sense advice and practical tips provide a comprehensive road map to help navigate the basic challenges of life with cancer. She covers everything from how to evaluate your health insurance to what to pack for hospital stays, all carefully laid out in an easy-to-navigate format so readers can find...

Cancer: Step Outside the Box

Cancer: Step Outside the Box
by Ty M. Bollinger (Author)


Now in its 6th Edition (recently updated in 2014) and with over 150,000 copies sold since 2006, Cancer-Step Outside the Box is a “must-have” book that everyone should own. According to Dr. Rashid Buttar, author of The 9 Steps to Keep the Doctor Away, “Ty Bollinger's book, Cancer-Step Outside the Box, is an extraordinarily thorough and courageously well written book, brought to fruition by the dedication of a son for his departed parents. I found it difficult to put down this exceptional book once I began reading it and plan on recommending it to all my patients suffering from cancer who seek treatment at our clinic so that the light of truth and hope contained within this book can shine brightly on them as well.” In the words of cancer survivor, Brad Matznick, “I am not a...

Cancer: 7 Powerful And Proven Cancer Cures You'll Never Hear About (Cancer, Cancer Cures, Cancer treatments, yoga, alternative cures, holistic medicine, alternative treatments)

Cancer: 7 Powerful And Proven Cancer Cures You'll Never Hear About (Cancer, Cancer Cures, Cancer treatments, yoga, alternative cures, holistic medicine, alternative treatments)


Cancer Cures: 7 Powerful and Proven Cancer Cures You Will Never Hear About
Today only, get this Amazon bestseller for just $3.05. Regularly priced at $4.99. Read on your PC, Mac, smart phone, tablet or Kindle device.

Western medicine is no closer to finding a "cancer cure," then it was 75 years ago.
Meanwhile cancer has grown into a worldwide epidemic of staggering proportions.

Despite the fact that there have been doctors, scientists and researchers who have discovered
apparently effective solutions against cancer, except none of them has ever been taken into
serious consideration by official medicine.

In fact, most of them were in fact rejected out-front, even though the cures were documented.
Anyone who dare bringing...

Radical Remission: Surviving Cancer Against All Odds

Radical Remission: Surviving Cancer Against All Odds
by Kelly A. Turner (Author)


In her New York Times bestseller, Radical Remission: Surviving Cancer Against All Odds, Dr. Kelly A. Turner, founder of the Radical Remission Project, uncovers nine factors that can lead to a spontaneous remission from cancer—even after conventional medicine has failed.While getting her Ph.D. at the University of California, Berkley, Dr. Turner, a researcher, lecturer, and counselor in integrative oncology, was shocked to discover that no one was studying episodes of radical (or unexpected) remission—when people recover against all odds without the help of conventional medicine, or after conventional medicine has failed.  She was so fascinated by this kind of remission that she embarked on a ten month trip around the world, traveling to ten different countries to interview fifty...

We Lost the War on Cancer - Review of Alternative Cancer Therapies

We Lost the War on Cancer - Review of Alternative Cancer Therapies
by Sophia Media, LLC


We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the...

The Gerson Therapy: The Proven Nutritional Program for Cancer and Other Illnesses

The Gerson Therapy: The Proven Nutritional Program for Cancer and Other Illnesses
by Charlotte Gerson (Author), Morton Walker D.P.M. (Author)


Cancer. Hepatitis. Migraines. Arthritis. Heart Disease. Emphysema. For years, the medical establishment has called these chronic or life- threatening diseases "incurable." But now, The Gerson Therapy offers hope for those seeking relief from hundreds of different diseases. Juice your way to wellness. One of the first alternative cancer therapies, The Gerson Therapy has successfully treated thousands of patients for over 60 years.

Now, in this authoritative revised and updated edition, alternative medicine therapist Charlotte Gerson and medical journalist Morton Walker reveal even more on the powerful healing effects of organic fruits and vegetables. Not only can juicing reverse the effects of many degenerative illnesses-it can save lives. The Gerson Therapy shows you:
...

Cancer: 50 Essential Things to Do: 2013 Edition

Cancer: 50 Essential Things to Do: 2013 Edition
by Greg Anderson (Author)


The ground-breaking classic guide to surviving cancer?now completely updated!

Revised and updated for the first time since 1999, this invaluable guide to cancer recovery offers an easily accessible plan for patients and family members. Written by a cancer survivor, the book is an inspiring, action-oriented roadmap for those who choose to adopt a stance of hope and take charge of their diagnosis.

With penetrating insights that bring together more than two decades of scientifically supported research and experience, Anderson reveals a step-by-step holistic action plan that has been successfully employed by hundreds of thousands of cancer patients worldwide. Anderson?s message is: ?You must not simply treat illness, you must also create wellness?physically, emotionally and...

Outsmart Your Cancer: Alternative Non-Toxic Treatments That Work (Second Edition) With CD

Outsmart Your Cancer: Alternative Non-Toxic Treatments That Work (Second Edition) With CD
by Tanya Harter Pierce (Author)


This easy-to-read alternative treatment guide could save your life. Outsmart Your Cancer explodes the myths about alternative cancer treatments and explains why non-toxic methods are more effective than conventional ones. This second edition of Outsmart Your Cancer includes new chapters, an audio CD with inspiring recovery testimonials from cancer survivors, and an incredible amount of valuable information. Twenty-one different alternative methods are discussed along with real-life stories of people who completely recovered from a variety of advanced or late-stage cancers using alternative approaches. The book explains why alternative methods work better than conventional toxic treatments and presents details about the scientific basis for them, including the amazing formula called...

© 2015 BrightSurf.com